Some pathways were found to be fundamental to CML development, such as regulation of protein kinase activity, processes related to cell division, and mitogen-activated-protein kinase (MAPK) activity. Here, WNK2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.